169 related articles for article (PubMed ID: 15574252)
1. [Acute leukemia in patients with Down syndrome].
Fernández-Plaza S; Sevilla J; Contra T; Martín N; Madero L
An Pediatr (Barc); 2004 Dec; 61(6):515-9. PubMed ID: 15574252
[TBL] [Abstract][Full Text] [Related]
2. Acute leukemias in children with Down syndrome.
Seewald L; Taub JW; Maloney KW; McCabe ER
Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
[TBL] [Abstract][Full Text] [Related]
3. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
[TBL] [Abstract][Full Text] [Related]
4. The treatment of children with acute megakaryoblastic leukemia who have Down syndrome.
Zipusky A
J Pediatr Hematol Oncol; 1996 Feb; 18(1):10-2. PubMed ID: 8556363
[No Abstract] [Full Text] [Related]
5. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
[TBL] [Abstract][Full Text] [Related]
7. An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Kojima S; Sako M; Kato K; Hosoi G; Sato T; Ohara A; Koike K; Okimoto Y; Nishimura S; Akiyama Y; Yoshikawa T; Ishii E; Okamura J; Yazaki M; Hayashi Y; Eguchi M; Tsukimoto I; Ueda K
Leukemia; 2000 May; 14(5):786-91. PubMed ID: 10803507
[TBL] [Abstract][Full Text] [Related]
8. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I;
J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827
[TBL] [Abstract][Full Text] [Related]
10. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and survival of children with acute leukemia with Down syndrome or other birth defects in New York State.
Qiao B; Austin AA; Schymura MJ; Browne ML
Cancer Epidemiol; 2018 Dec; 57():68-73. PubMed ID: 30326394
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
[TBL] [Abstract][Full Text] [Related]
13. Late mortality and morbidity among long-term leukemia survivors with Down syndrome: A nationwide population-based cohort study.
Vonasek J; Asdahl P; Heyman M; Källén K; Hasle H
Pediatr Blood Cancer; 2018 Sep; 65(9):e27249. PubMed ID: 29797653
[TBL] [Abstract][Full Text] [Related]
14. Leukemia in Down syndrome: a review.
Zipursky A; Poon A; Doyle J
Pediatr Hematol Oncol; 1992; 9(2):139-49. PubMed ID: 1388043
[TBL] [Abstract][Full Text] [Related]
15. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK
Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
[TBL] [Abstract][Full Text] [Related]
16. Acute leukemias in children with Down syndrome.
Zwaan MC; Reinhardt D; Hitzler J; Vyas P
Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
[TBL] [Abstract][Full Text] [Related]
17. Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004.
Hassler A; Bochennek K; Gilfert J; Perner C; Schöning S; Creutzig U; Reinhardt D; Lehrnbecher T
Pediatr Blood Cancer; 2016 Jun; 63(6):1070-4. PubMed ID: 26814618
[TBL] [Abstract][Full Text] [Related]
18. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial.
Teyssier AC; Lapillonne H; Pasquet M; Ballerini P; Baruchel A; Ducassou S; Fenneteau O; Petit A; Cuccuini W; Ragu C; Preudhomme C; Mercher T; Sirvent N; Leverger G
Pediatr Hematol Oncol; 2017 Nov; 34(8):425-427. PubMed ID: 29303660
[TBL] [Abstract][Full Text] [Related]
19. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]